Skip to main content

Table 1 Population characteristics

From: Free breathing three-dimensional cardiac quantitative susceptibility mapping for differential cardiac chamber blood oxygenation – initial validation in patients with cardiovascular disease inclusive of direct comparison to invasive catheterization

Age63 ± 10yo
Gender (% male)31% (12)
Known CAD56% (22)
Pulmonary Hypertension51% (20)
Atherosclerosis Risk Factors
Tobacco Use (prior or current)46% (18)
Hypertension67% (26)
Hyperlipidemia54% (21)
Diabetes mellitus18% (7)
Medication Regimen
ACE Inhibitors or ARB51% (20)
Beta-Blockers72% (28)
Aspirin74% (29)
Statin69% (27)
Diuretic46% (18)
Cardiac Structure/Function
LVEF (%)49 ± 14%
LV Dysfunction (EF < 50%)49% (19)
LV End-Diastolic Volume186 ± 57 ml
LV End-Systolic Volume106 ± 56 ml
RV EF (%)51 ± 11%
RV Dysfunction (EF < 50%)31% (12)
RV End-Diastolic Volume169 ± 62 ml
RV End-Systolic Volume96 ± 52 ml
  1. Data reported as % (n) for categorical variables, mean standard deviation for continuous variables
  2. ACE angiotensin converting enzyme, ARB angiotensin receptor blocker, CAD coronary artery disease, EF ejection fraction, LV left ventricle, RV right ventricular